Alendronate-modified hydroxyapatite nanoparticles for bone-specific dual delivery of drug and bone mineral

Seok Joon Hwang, Ji Seon Lee, Tae Kyung Ryu, Rae Hyung Kang, Ki Young Jeong, Dae Ryong Jun, Jung Min Koh, Sung Eun Kim, Sung Wook Choi

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Abstract

Alendronate (Alen)-modified hydroxyapatite (HAp) nanoparticles with multilayers of poly(allylamine) (PAA) and alginate (ALG) were fabricated for bone-specific dual delivery of drug and mineral. Negatively charged HAp nanoparticles were coated with three layers of PAA and ALG using a layer-by-layer (LbL) method and then conjugated with Alen at the outmost layer of the LbL-coated HAp nanoparticles via carbodiimide chemistry. Alen-modified HAp nanoparticles had a spherical morphology and an average size of 61.5 nm. The superior adsorption property of the Alen-modified HAp nanoparticles was quantitatively confirmed using tricalcium phosphate disks as a bone model, compared to HAp nanoparticles. Cell culture assays revealed a higher proliferation rate and alkaline phosphatase activity of osteoblasts treated with the Alen-modified HAp nanoparticles. [Figure not available: see fulltext.]

Original languageEnglish
Pages (from-to)623-628
Number of pages6
JournalMacromolecular Research
Volume24
Issue number7
DOIs
StatePublished - 1 Jul 2016

Bibliographical note

Publisher Copyright:
© 2016, The Polymer Society of Korea and Springer Sciene+Business Media Dordrecht.

Keywords

  • alendronate
  • dual targeted delivery
  • hydroxyapatite
  • layer-by-layer method

Fingerprint

Dive into the research topics of 'Alendronate-modified hydroxyapatite nanoparticles for bone-specific dual delivery of drug and bone mineral'. Together they form a unique fingerprint.

Cite this